33 filings
Page 2 of 2
8-K
icb 9yr9dns8yxh
5 Jan 22
Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer
5:04pm
8-K
tiaqy50z3y uv2lrx
15 Nov 21
Spruce Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
12:00am
8-K
h6fptd 02sysgnndwki6
15 Sep 21
Regulation FD Disclosure
9:01am
8-K
nh4xj59j
25 Aug 21
Regulation FD Disclosure
11:02am
8-K
tutt uuaq8u7n5l
10 Aug 21
Spruce Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
4:14pm
8-K
egrrj
29 Jun 21
Departure of Directors or Certain Officers
4:12pm
8-K
nhiplpnk
24 May 21
Submission of Matters to a Vote of Security Holders
4:37pm
8-K
4k6aem00uw1rfqqj7z
12 May 21
Spruce Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Updates
4:09pm
8-K
3usi 4soyaxkjcoh
22 Mar 21
Spruce Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Recent Corporate Updates
4:18pm
8-K
onw cbly7z3e
25 Feb 21
Departure of Directors or Certain Officers
11:00am
8-K
3ho xskw0w
6 Jan 21
Spruce Biosciences Provides Corporate Update and Outlines Milestones for 2021
9:01am
8-K
7oprfyyahncir
18 Nov 20
Spruce Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:07pm
8-K
kpawiyg0gxco81ueybc2
14 Oct 20
Spruce Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise
4:21pm